Iohexol Icg Farma

Iohexol, the active ingredient in Iohexol Icg Farma, is an iodinated contrast media presented as a sterile solution for intra‑arterial, intravenous or intrathecal use. It provides radiodense contrast that enhances the visibility of vascular structures and body cavities during imaging procedures, facilitating accurate diagnosis in patients undergoing radiographic examinations.

GNH USA supplies Iohexol Icg Farma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Iohexol is used as an iodinated contrast agent to improve imaging of vascular and organ systems. - Angiography: enhances visualization of blood vessels for diagnostic and interventional procedures. - Computed tomography (CT) imaging: increases attenuation of X‑rays to delineate anatomical detail. - Myelography: provides contrast within the spinal canal for assessment of the central nervous system. - Urography: highlights the urinary tract to detect obstructions or lesions. - Contrast‑enhanced radiographic examinations: improves overall image quality for a range of radiographic studies.

Adverse reactions to iodinated contrast media may vary in frequency and severity.

Common Side Effects: - Warm sensation or flushing at the injection site. - Mild nausea or vomiting. - Transient headache. - Temporary metallic taste. - Mild itching or urticaria. - Low‑grade hypotension.

Serious or Rare Side Effects: - Severe allergic reactions (anaphylaxis). - Acute kidney injury, especially in patients with pre‑existing renal impairment. - Cardiac arrhythmias. - Pulmonary edema. - Seizures. - Contrast‑induced neurotoxicity.

When using Iohexol, clinicians should assess patient risk factors and monitor for reactions. - Renal function assessment: evaluate serum creatinine before administration in at‑risk patients. - Allergy history: screen for prior contrast reactions or iodine sensitivity. - Hydration status: ensure adequate fluid intake to reduce nephrotoxicity risk. - Concomitant nephrotoxic drugs: consider dose adjustment or alternative imaging. - Pregnancy and lactation: use only if clearly needed after risk‑benefit evaluation. - Store at ambient temperature: keep in original container, protect from light and moisture.

Iohexol may interact with other agents that affect renal function or hypersensitivity risk.

Major Interactions (Avoid): - Nephrotoxic drugs (e.g., aminoglycosides, amphotericin B): increase risk of renal injury. - High‑dose iodinated medications (e.g., amiodarone): may potentiate iodine load.

Moderate Interactions (Monitor Closely): - Diuretics: may exacerbate dehydration‑related kidney stress. - Metformin: consider temporary discontinuation in patients with impaired renal function. - Beta‑blockers: may mask early signs of anaphylaxis. - ACE inhibitors or ARBs: monitor blood pressure and renal parameters.